Aerpio Therapeutics is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/30/12 | $27,000,000 | Series A |
AgeChem Venture Fund Kearny Venture Partners Novartis Venture Funds Triathlon Medical Ventures Venture Investors | undisclosed |
| 11/07/13 | $9,000,000 | Series A-2 |
Kearny Venture Partners Novartis Venture Funds Satter Investment Management Triathlon Medical Ventures Venture Investors | undisclosed |
| 04/23/14 | $22,000,000 |
Kearny Venture Partners Novartis Venture Funds OrbiMed Advisors Satter Investment Management Triathlon Medical Ventures | undisclosed |
